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Introduction
To address antimicrobial resistance, antibiotics should be 
used appropriately in human medicine. Patients should 
receive antibiotics “appropriate to their clinical needs, in 
doses that meet their own individual requirements, for an 
adequate period of time”.4 Similar rules apply to the prudent 
use of antibiotics by all of the relevant stakeholders involved 
in veterinary medicine.5
The inappropriate use of antibiotics may involve the use 
of antibiotics for a health problem for which antibiotics are 
not indicated or the rational use of antibiotics either in doses 
that are inadequate or in the correct doses, but for an inad-
equate duration. As exposure of susceptible bacteria to low 
doses of antibiotics can lead to the selection of resistance,1 
there is a strong association between antimicrobial resistance 
and inappropriate use of antibiotics at both individual and 
population levels.2,3
In most developing countries, many antibiotics can be 
easily bought without prescription and self-medication with 
antibiotics, mostly bought from drugstores or pharmacies or 
left over from previous treatments, is common.6,7 Such self-
medication is also found in some high-income countries.8
A major aim of the pharmaceutical market is to respond 
to increased demand. As the number of retail pharmacies 
and other outlets for the distribution of antibiotics increases, 
antibiotics become more widely and easily available. Health 
professionals may also be persuaded to over-prescribe anti-
biotics by financial incentives.9
In low- and middle-income countries most drug regula-
tion is focussed on the quality of drugs and the process of 
licensing; relatively little attention is given to distribution, 
price and other aspects of market control. Furthermore, in 
such countries, the enforcement of the drug regulations that 
do exist is often poor and the sale of substandard over-the-
counter antibiotics and weak pharmaco-vigilance are often 
common.10–12
One of the main aims of the Global Action Plan on Anti-
microbial Resistance, which was adopted by the World Health 
Assembly in 2015, was to optimize the use of antibiotics in 
human and veterinary medicine.13 A key goal of Thailand’s 
subsequent National Action Plan on Antimicrobial Resistance, 
which was developed and endorsed by the Thai Cabinet in 
2016, was to reduce antibiotic consumption, by 20% in human 
medicine and by 30% in veterinary medicine by 2021.
In 2009, the value of the antibiotics imported into Thai-
land or manufactured in the country was about 315 million 
United States dollars and this value represented about 10% of 
the total value of the medicines consumed in the country.15 
There appears to be widespread and often unregulated use of 
antibiotics, not only for human and pet health, but also for the 
treatment of livestock both on farms and in household settings.
In 2016, we decided to investigate Thailand’s importation, 
manufacture, distribution and regulation of antibiotics. In 
interviews with key informants, we investigated the multiple 
channels for the distribution of antibiotics, from import and 
manufacture to retail sale, and the various issues that probably 
contribute to the inappropriate use of antibiotics.
Objective To analyse how antibiotics are imported, manufactured, distributed and regulated in Thailand.
Methods We gathered information, on antibiotic distribution in Thailand, in in-depth interviews – with 43 key informants from farms, 
health facilities, pharmaceutical and animal feed industries, private pharmacies and regulators– and in database and literature searches.
Findings In 2016–2017, licensed antibiotic distribution in Thailand involves over 700 importers and about 24 000 distributors – e.g. retail 
pharmacies and wholesalers. Thailand imports antibiotics and active pharmaceutical ingredients. There is no system for monitoring the 
distribution of active ingredients, some of which are used directly on farms, without being processed. Most antibiotics can be bought from 
pharmacies, for home or farm use, without a prescription. Although the 1987 Drug Act classified most antibiotics as “dangerous drugs”, it 
only classified a few of them as prescription-only medicines and placed no restrictions on the quantities of antibiotics that could be sold 
to any individual. Pharmacists working in pharmacies are covered by some of the Act’s regulations, but the quality of their dispensing and 
prescribing appears to be largely reliant on their competences.
Conclusion In Thailand, most antibiotics are easily and widely available from retail pharmacies, without a prescription. If the inappropriate 
use of active pharmaceutical ingredients and antibiotics is to be reduced, we need to reclassify and restrict access to certain antibiotics and 
to develop systems to audit the dispensing of antibiotics in the retail sector and track the movements of active ingredients.
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Methods
We investigated antibiotic distribution 
and regulation in Thailand using a com-
bination of key-informant interviews, a 
review of the relevant drug regulations 
and database searches.
Interviews
Between the July and November of 2016, 
we conducted in-depth interviews, last-
ing a mean of 90 minutes, with 43 key 
informants. Each interviewee had been 
selected using a purposive sampling 
technique in which relevant associations, 
i.e. Thailand’s Animal Health Products, 
Animal Feed Mill, Community Phar-
macy and Pharmaceutical Manufactur-
ers Associations, were asked to propose 
lists of their members who could provide 
information about antibiotic distribu-
tion. Each potential informant identified 
was asked if they were able and willing 
to participate in the study and, if so, they 
were asked to give their written informed 
consent. Our initial aim was to recruit at 
least three consenting informants from 
each of six main stakeholder groups, i.e. 
animal feed industries, farms, govern-
ment authorities in the fields of human 
and animal health, health facilities, phar-
maceutical industries and pharmacies. 
However, using the snowball technique, 
more key informants were interviewed 
until our data became saturated and no 
new information emerged (Table 1). To 
ensure consistency, the same individual 
(AS) interviewed each key informant.
All of the interviews were con-
ducted face-to-face, in Thai. They were 
semi-structured, but based on open-
ended questions. The informants were 
asked about the processes of antibiotic 
import, manufacturing, distribution, 
dispensing, prescription and use. For 
example, they were asked about the 
sources of active pharmaceutical in-
gredients used in the manufacture of 
finished products and about their sale 
patterns. All of the interviewees were 
asked about the licensing process and 
requirements for each distributor, the 
registration of medicines and the factors 
that might contribute to the excessive 
and inappropriate use of antibiotics. The 
informants representing the farming 
industry or health facilities were asked 
about their sources of antibiotics and 
the processes they followed to purchase 
such drugs or active pharmaceutical 
ingredients. The data recorded in each 
interview were kept confidential.
Database searches
We estimated the numbers of licensees 
involved in antibiotic distribution in 
the Thai market and in the regulation 
of such distribution by analysing the 
relevant databases held by the Thai 
Food and Drug Administration32 and 
the Thai Department of Livestock De-
velopment.14
Drug regulations
We reviewed all of the regulations pro-
mulgated by both of the Acts that, in 
2016, regulated the use of antibiotics 
and medicated feed through inspection, 
licensing and marketing: the 1987 Drug 
Act30 and the 2015 Animal Feed Qual-
ity Control Act.31 The 1987 Drug Act, 
enforced by the Food and Drug Admin-
istration of the Thai Ministry of Public 
Health, regulates the finished products 
used in human and veterinary medicine 
and active pharmaceutical ingredients. 
The 2015 Animal Feed Quality Control 
Act is enforced by the Department of 
Livestock Development of the Thai Min-
istry of Agriculture and Cooperatives. 
Data analysis
The data obtained from the key-infor-
mant interviews and document reviews 
were summarized to provide an over-
view of the distribution of antibiotics 
and identify weaknesses that could 
contribute to the inappropriate use of 
antibiotics. To assess the accuracy of the 
interview data, we used triangulation 
across the 43 interviewees. If informa-
tion from one interviewee differed 
substantially from, and contradicted, 
the corresponding information from 
another interviewee, both pieces of 
information were ignored. Thailand’s 
antibiotic distribution channels were 
summarized as a system flowchart. The 
provincial numbers of licensed private 
pharmacies per 100 000 population were 
mapped using ArcGIS software (Esri, 
Redlands, United States of America).
Ethics
The study protocol was approved by the 
Research Ethics Committee at the Thai 
Ministry of Public Health’s Institute for 
Development of Human Research. In-
terviewees gave their written informed 
consent. Strict confidentiality was ob-
served and interviewees could opt out 
from the interviews at any time.
Results
We created a flowchart, based on data 
from the key-informant interviews and 
reviews of the 1987 Drug Act and the 
2015 Animal Feed Quality Control Act, 
to summarize the antibiotic distribu-
tion channels (Fig. 1). It illustrates the 
complexity of the distribution, of active 
pharmaceutical ingredients, finished 
products and medicated feed, from the 
importers and local manufacturers to 
final consumption by humans, livestock 
or pets.
Import, manufacture and 
distribution
Thailand imported active pharmaceuti-
cal ingredients, for local manufacturing 
into finished products. It also imported 
medicated premix for the manufacture 
Table 1. Types, ages and years in relevant work of the 43 key informants, Thailand, 2016
Type No. of 
informants
Ages (years) Relevant work experi-
ence (years)a
Mean Range
Regulator 13 35–59 15.9 0.5–32.0
Representative of 
pharmaceutical companyb
14 35–65 17.1 3.0–40.0
Representative of animal feed 
companyc
5 30–61 18.5 3.5–37.0
Health professional from human 
or animal health facility
4 35–54 14.3 1.0–31.0
Wholesaler or owner of retail 
drug store
4 36–70 25.5 11.0–42.5
Farmer 3 37–52 16.6 13.0–19.0
Total 43 30–70 17.2 0.5–42.5
a  Recorded after rounding to the nearest half year.
b  Involved in the import, manufacturer and/or distribution of antibiotics.
c  Running a feed mill or feed store.
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of medicated feed by feed mills. Ac-
tive pharmaceutical ingredients were 
imported either by manufacturers or 
by licensed importers that then sold the 
ingredients to manufacturers. Most of the 
manufacturers either purchased active 
pharmaceutical ingredients from licensed 
importers or imported such ingredients 
themselves – rather than buying them, 
at a greater cost, from drugstores. The 
antibiotics produced by the manufac-
turers were sold to distributors, retail 
outlets and/or wholesalers. The imported 
finished products were distributed, by 
importers who were licensed to distribute 
or by distributors, to drugstores, farms, 
feed mills, health facilities, veterinary 
facilities and/or wholesalers. Our data in-
dicated that the import and manufacture 
of human medicines were very similar to 
those of veterinary medicines, because 
the Thai Food and Drug Administration 
regulated all of these processes.
Several interviewees, representing 
regulators, retailers and wholesalers, 
described the illegal distribution of both 
finished products and certain active 
pharmaceutical ingredients. The 1987 
Drug Act stipulates that all active phar-
maceutical ingredients must be used by 
manufacturers to produce finished prod-
ucts. However, a few informants report-
ed how drug inspectors had confiscated 
active pharmaceutical ingredients that 
were being used directly on livestock in 
farms. The interviewees that represented 
the farming industry reported how the 
high cost of buying medicated feed had 
persuaded some farmers to mix active 
pharmaceutical ingredients into their 
animal feed. The farmers who produced 
their own medicated feed did not have 
quality control and, in the interviewees’ 
opinion, the feed they produced was 
unlikely to have an even distribution 
of active pharmaceutical ingredients. 
Although the 2015 Animal Feed Quality 
Control Act prohibited such direct use 
of active pharmaceutical ingredients 
in animal feed, inadequate inspection 
allowed farmers to purchase such ingre-
dients from drugstores or wholesalers.
According to the various ministe-
rial notifications and regulations pro-
mulgated by the 1987 Drug Act, most 
antibiotics are classified as “dangerous 
drugs” that can only be dispensed by 
licensed pharmacists in pharmacies, 
but can be obtained, legally, without 
a prescription. Only a few antibiotics, 
e.g. betalactamase inhibitor, carbapen-
ems and fosfomycin, are classified as 
special-control drugs because of the 
high prevalence of resistance to them. 
Such drugs cannot be obtained, legally, 
without a prescription and are reserved 
for hospital use.
According to our interviews with 
key informants representing the coun-
try’s health providers, every private 
and public clinic and hospital had a 
pharmacy section in which antibiotics 
were dispensed to inpatients and out-
patients according to the prescriptions 
of doctors. Although most of these 
prescriptions were not required by law, 
the routine issuing of prescriptions, even 
for drugs that were not, legally, prescrip-
tion-only, had become the tradition of 
most health facilities. Antibiotics were 
also dispensed directly to consumers 
Fig. 1. Antibiotic distribution channels, Thailand, 2016
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and pet owners by licensed pharmacists 
in wholesalers or drugstores.
Informants representing animal 
feed companies reported how feed 
mills mostly purchased medicated pre-
mix, from importers, manufacturers 
or distributors, to produce medicated 
feed that was then sold to farms either 
directly or via feed stores. According to 
the key informants from the farming 
industry, most of the antibiotics that 
farmers used were given to livestock in 
medicated feed, either for treatment or 
for prophylaxis during periods of in-
creased vulnerability, e.g. when livestock 
were transferred to new environments.
The large number of licensed indi-
viduals involved in the antibiotic supply 
chains can be categorized according to 
the type of license granted to them un-
der the 1987 Drug Act or 2015 Animal 
Feed Quality Control Act. According to 
the licenses issued in 2016–2017, these 
chains involved 793 drug importers, 187 
drug manufacturers, 323 animal feed 
importers, 299 animal feed mills, 27 165 
feed stores and about 24 000 other indi-
viduals who were distributors, whole-
salers or retail pharmacies (Table 2). Of 
the 793 importers involved in antibiotic 
distribution, 675 (85%) were located in 
Bangkok, the capital city where the main 
air and sea ports are located.32 From 
Bangkok, many medicines, including 
antibiotics, are distributed throughout 
the country by importers, manufactur-
ers and wholesalers, with sales driven, 
as usual, by market forces. In 2016, 
the provinces of Bangkok, Chonburi 
and Phuket had more than 61 licensed 
private pharmacies per 100 000 popula-
tion (Fig. 2).
Our database searches revealed 
how, in 2015, about 3.1 million Thai 
households raised chickens (n = 2.4 
million), ducks (n = 0.4 million), buffalo 
(n = 0.2 million) and/or pigs (n = 0.2 
million).14
Market authorization and 
licensing
Overall, 5371 antibiotics were registered 
in the Thai Food and Drug Administra-
tion’s database for 2016.34 Of these, 3371 
(63%) were registered for human use 
and the rest for use on livestock and 
pets, some as medicated premix. The 
database records did not distinguish 
between imported antibiotics and those 
produced in Thailand.
The importation of any drugs must 
be registered and pre-approved by the 
Thai Food and Drug Administration. By 
law, active pharmaceutical ingredients 
must only be sold by licensed import-
ers and manufacturers. At customs, the 
licensed importers of active pharmaceu-
tical ingredients are required to notify 
the Thai Food and Drug Administration 
before gaining approval for imports.
The 1987 Drug Act regulates phar-
macists working in pharmacies, on 
aspects such as working hours and the 
dispensing of special-control drugs. 
However, most of the dispensing of 
antibiotics classified as dangerous drugs 
is not legally regulated and the quality 
of dispensing is largely reliant on the 
competences of the doctors, pharmacists 
and veterinarians involved. Historically, 
there have been no legal requirements 
for the keeping of records on the types 
and quantities of antibiotics dispensed 
within the retail sector. At the time of 
our study, prescriptions were routinely 
issued in hospitals, but no prescription 
audits were required.
Discussion
Our study was triggered by the Global 
Action Plan on Antimicrobial Resis-
tance. In this study, we identified a few 
key challenges, on both the demand 
and supply sides of the market as well 
as in health facilities and the regulatory 
environment, that perhaps made access 
to antibiotics too easy (Fig. 3).
Demand by patients and farmers
Self-medication with antibiotics ob-
tained without a prescription is a com-
mon practice in most developing coun-
tries.16 Although such self-medication 
may appear to be a relatively cheap 
option for the sick and their house-
hold carers, the societal cost of such 
treatment, often associated with inap-
propriate drugs or appropriate drugs 
in inadequate or suboptimal doses, and 
with a lack of counselling by the drug 
provider, can be relatively high. In China 
and Viet Nam, inadequate knowledge 
and lack of awareness of antimicrobial 
resistance, in both patients and provid-
ers, were recognized as important fac-
tors contributing to the irrational use of 
antibiotics.17 Inadequate regulation of 
drug distribution and sales may result in 
easy access, especially when, as is often 
Table 2. The types and numbers of individuals involved in the distribution of antibiotics 
and other medicines, Thailand, 2016–2017
Type License held No. of 
individuals
Licensed providers 
Medicine importers Pharmaceutical import 793a
Medicine manufacturers Pharmaceutical manufacture 187a
Medicine distributors Pharmaceutical sales NAa
Medicine wholesalers Pharmaceutical sales NAa
Retail drug stores or pharmacies  
    Selling all medicines Pharmaceutical sales NAa
    Selling only ready-packed medicines Pharmaceutical sales – ready-
packed medicines only
3164a
    Selling only ready-packed medicines for animals Pharmaceutical sales – 
ready-packed medicines for 
animals only
763a
Human health facilities Health facility 11 560b
Importers of animal feed Animal feed import 323c
Animal feed mills Animal feed manufacture 299c
Animal feed stores Animal feed sales 27 165c
Animal health facilities Animal health facility 2058d
Unlicensed individuals
Households involved in the rearing of livestock None 3 102 530e
NA: not available.
a  In 2017, according to the Thai Food and Drug Administration’s records, there were 19 934 individuals 
holding full pharmaceutical sales licenses in Thailand.32
b  Data from the Thai Ministry of Public Health’s records for 2016.33
c  Data from the Thai Department of Livestock Development’s records for 2016.35
d  Data from the Thai Department of Livestock Development’s records for 2016.36
e  The estimated number of households involved in the rearing of livestock.14
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the case in Thailand, prescriptions are 
not required. In turn, easy access may 
boost the inappropriate use of drugs by 
households.18,19
Supply problems
Any economic incentives offered by 
pharmaceutical companies to boost 
their market share may contribute to 
the excessive provision of antibiotics.17 
Some pharmaceutical companies sup-
port clinicians by sponsoring continu-
ing professional education, financing 
international travel for conferences 
and leisure or offering generous speak-
ing fees.20–22 In an attempt to break the 
link between such incentives and the 
preferential dispensing of drugs pro-
duced by the company providing the 
incentives, Denmark has decoupled the 
prescribing and dispensing of medicines 
by veterinarians.23 Almost all medicines 
used in the livestock sector in Denmark 
are now sold directly to the farmers by 
pharmacies.23
In much of Asia, the quality of the 
pharmaceutical services provided by 
retail pharmacies is often poor. The 
staff in such pharmacies may offer no 
counselling or history taking and may 
recommend inappropriate presump-
tive treatments, e.g. antibiotics for the 
treatment of the symptoms of a common 
cold or influenza, or appropriate drugs 
in suboptimal doses.24 Suboptimal doses 
may be all that the patient can afford. In 
Peru and central Thailand, private retail 
pharmacies, where dispensing could not 
be guided by the antibiotic-resistance 
profiles of the causative agents, were 
found to be the most common source of 
antibiotics for the treatment of sexually 
transmitted diseases.25,26
In Thailand, we identified about 
24 000 distributors, retailers and whole-
salers who were fully licensed for phar-
maceutical sales in 2017. At the time 
of our study, the records of the Thai 
Food and Drug Administration did 
not differentiate between such licensed 
distributors, retailers and wholesalers. In 
consequence, there was no easy way to 
monitor or control the sale of large quan-
tities of antibiotics to individual patients 
or farmers. We found that, if they could 
afford it, Thai farmers could easily buy 
very large amounts of finished products 
and active pharmaceutical ingredients 
from drug retailers or wholesalers.
Regulatory environment
The focus of drug regulation in low- and 
middle-income countries, e.g. Ethiopia, 
Thailand, the United Republic of Tanza-
nia and Zimbabwe, is on drug quality 
and licensing rather than availability 
and distribution channels.10–12
In Thailand, the 1987 Drug Act did 
attempt to regulate the availability of 
some antibiotics, by dividing antibiotics 
into a large group of “dangerous drugs 
not requiring prescriptions” and a much 
smaller group of “special-control drugs 
requiring prescriptions”.30 This categori-
zation meant that most antibiotics could 
be dispensed, by licensed pharmacists 
in retail pharmacies, without a pre-
scription. Furthermore, the Act made 
no attempt to regulate the quantity of 
antibiotics that could be distributed to 
any individual or to control the excessive 
use of antibiotics in livestock. Later, the 
2015 Animal Feed Quality Control Act 
prohibited direct use of active pharma-
ceutical ingredient in the animal feeds. 
However, our interviews indicated that, 
many Thai farmers were, illegally, add-
ing active pharmaceutical ingredients to 
animal feeds, probably as a cost-saving 
measure.
Following a series of public consul-
tations, the Thai Food and Drug Admin-
istration is working on a reclassification 
of antibiotics in which a larger propor-
tion of the drugs will be categorized as 
special-control/prescription-only, in 
line with the recommendations made 
by the World Health Organization in its 
20th Model List of Essential Medicines.27
Compared with access to antibi-
otics, access to active pharmaceutical 
ingredients appears to be less well 
regulated, leading to inappropriate 
use by farmers. In Thailand, all drugs 
have to be registered with the Food and 
Drug Administration before produc-
tion or importation. There is, however, 
no corresponding requirement for the 
Fig. 2. Provincial numbers of private licensed retail pharmacies per 100 000 population, 
Thailand, 2016
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Source: Based on data from the Thai Food and Drug Administration’s records for 2017.32
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registration of active pharmaceutical 
ingredients. Drug distributors and 
retailers can only sell active pharmaceu-
tical ingredients legally to manufactur-
ers. However, a lack of monitoring and 
tracking of active pharmaceutical ingre-
dients and inadequate inspections at the 
drug distributors and retailers mean that 
this legal restriction is generally ignored.
One limitation of our study is that 
the data maintained by the Thai Food 
and Drug Administration do not allow 
any estimation of the national consump-
tion of each major class of antibiotics in 
terms of, for example, the defined daily 
dose per 1000 inhabitants per day. The 
Thai Working Group on the Surveillance 
of Antimicrobial Consumption is work-
ing on the development of a sustainable 
system to monitor annual antimicrobial 
consumption.28
In conclusion, this study appears to 
be the first published study in Thailand 
to investigate antibiotic distribution, for 
human and animal health. The thou-
sands of drug distributors, drug whole-
salers, retail pharmacies and animal feed 
stores that have arisen in the country, as 
a result of market forces, and the small 
number of antibiotics that are classified 
as special-control/prescription-only 
make most antibiotics easily and widely 
available in both the human and animal 
health sectors. Such wide availability 
probably leads to frequent inappropriate 
use. A general lack of enforcement of the 
legislation covering the distribution of 
active pharmaceutical ingredients facili-
tates the direct use of such ingredients 
on farms.
The unnecessary and inappropriate 
use of antibiotics will probably lead to 
an increase in the problem posed by 
antimicrobial resistance in Thailand. A 
system for recording antibiotic dispens-
ing at retail pharmacies should be estab-
lished29 and then carefully audited by 
pharmacists. The continued professional 
education of retail pharmacists should 
be promoted, as a means of reducing 
the inappropriate use of antibiotics, and 
other drugs. The sales of large quantities 
of antibiotics to individuals need to be 
restricted by differentiating wholesalers 
from retailers in the licensing system. 
This includes prohibiting wholesalers 
from selling large quantities of antibi-
otics to farmers, or others who are not 
licensed retail outlets, and carefully 
restricting the sale by retailers of large 
quantities of such drugs to individuals. 
The ongoing policy to reclassify more 
antibiotics as special-control/prescrip-
tion-only drugs in Thailand should be 
rapidly implemented. A national sys-
tem for tracking active pharmaceutical 
ingredients should be established im-
mediately, to prevent the direct use of 
such ingredients on farms.  ■
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Fig. 3. Factors potentially contributing to the excessive and/or inappropriate use of 
antibiotics, Thailand, 2016
Regulations and enforcement capacity
• Leakage of illegal API into the market, potential abuse in agricultural sector
• Unregulated leakage of API into the market, allowing their potential abuse in agricultural sector
• Antibiotics classified by Thai-FDA as pharmacy dispensing only and no prescription requirement
• Lack of audits on prescription and dispensing records
Health systems
• Lack of information systems to capture magnitude of self-medication of antibiotics
• Lack of AMR surveillance system to support decision of health professionals
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appropriate use of antibiotics
• Cheaper for households to seek antibiotics 
from private pharmacies than clinics, 
hospitals and other formal providers for 
common ailments
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based on opinion and experiences
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decision on antibiotic 
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AMR: antimicrobial resistance; API: active pharmaceutical ingredients; FDA: Food and Drug 
Administration.
صخلم
 يرقاقعلل ةيميظنتلا حئاوللا تاعجارمو ينسيئرلا ينغلبلما عم تلاباقلما جئاتن :دنليات في ةيويلحا تاداضلما عيزوت تاونق
تانايبلا ةدعاق في ثحبلا تايلمعو
 اهعيزوتو اهعينصتو ةيويلحا تاداضلما دايرتسا ةيفيك ليلتح ضرغلا
.دنليات في اهميظنتو
 في  ةيويلحا  تاداضلما  عيزوت  لوح  تامولعم  عمجب  انمق  ةقيرطلا
 عرازلما نم ينسيئرلا ينغلبلما نم 43 عم ةقمعتم تلاباقم في دنليات
 تاناويلحا فلعو ةيئاودلا تاجتنلما تاعانصو ةيحصلا تآشنلماو
 تانايبلا  ةدعاق  في  كلذكو  ،ينمظنمو  ةصالخا  تايلديصلاو
.تافلؤلما ثاحبأو
 تاداضملل صخرلما عيزوتلا نمضت 2017-2016 ماع في جئاتنلا
 عزوم  فلأ 24  لياوحو  دروتسم 700  نم  رثكأ  دنليات  في  ةيويلحا
 .ةلملجا  يعئابو  روهمجلل  ةئزجتلاب  عيبت  يتلا  تايلديصلا  لثم
 نود ةطشنلا  ةيئاودلا  تانوكلماو ةيويلحا تاداضلما  دنليات  دروتست
 اهضعب مدختسُي يتلاو ،ةطشنلا تانوكلما عيزوت ةبقارلم ماظن دوجو
 ءاشر  نكملما  نمو  .ةلجاعملل  اهعوضخ  نود  عرازلما  في  ةًشرابم
 وأ لزانلما في اهمادختسلا تايلديصلا نم ةيويلحا تاداضلما مظعم
 ماعل يرقاقعلا  نوناق نأ نم مغرلا  لىعو .ةيبط ةفصو نود عرازلما
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 ،“ةيرطخ يرقاقعك”  ةيويلحا تاداضلما بلغأ فنصيل ءاج 1987
 ،بيبطلا  رمأب  لاإ  فصرُت لا يرقاقعك اهنم ليلقلا  طقف فنص دقف
 حّصرلما  ةيويلحا  تاداضلما  تايمك  لىع  دويق  يأ  ضرفي  نأ  نود
 يتلا  نوناقلل  ةيذيفنتلا  حئاوللا  نم ٌضعب  كانهو .درف  يلأ اهعيبب
 ةدوج  نأ  ودبي  هنأ  لاإ  تايلديصلا  في  ينلماعلا  ةلدايصلا  يطغت
 .متهءافك ىوتسم لىع يربك لكشب فقوتت اهفصرو ةيودلأل مهفصو
 لىعو  ةلوهسب  دنليات  في  ةيويلحا  تاداضلما  مظعم  رفوتت  جاتنتسلاا
 .ةيبط ةفصو نود روهمجلل عيبت يتلا تايلديصلا ىدل عساو قاطن
 تانوكملل  لثملأا  يرغ  مادختسلاا  نم  دلحا  مزتعلما  نم  ناك  اذإو
 فينصت ةداعإ انمزلي فوسف ،ةيويلحا تاداضلماو ةطشنلا ةيئاودلا
 عضو نع ًلاضف ،اهفصر لىع دويق ضرفو ةنيعم ةيويح تاداضم
 ،ةئزجتلاب  عيبلا  عاطق  في  ةيويلحا  تاداضلما  فصر  ةعجارلم  ةمظنأ
 .ةطشنلا تانوكلما مادختسا هجوأ عبتتو
摘要 
泰国的抗生素销售渠道 ：关键知情人访谈结果、药品监管审查和数据库检索
目的 分析泰国的抗生素是如何进口、加工、销售和监
管的。
方法 我们收集了泰国的抗生素销售信息，深入采访了
来自农场、医疗机构、制药和动物饲料行业、私人药
店和监管机构的 43 名关键知情人，并进行了数据库
和文献检索。
结果 2016-2017 年，泰国获得许可的抗生素销售涉
及 700 多家进口和 24000 家分销商——例如零售药店
和批发商。泰国进口抗生素和活性药物成分。目前还
没有用于监测活性成分的分配的系统，其中一些未经
过处理而直接在农场使用。大多数抗生素可以从药店
购买，供家庭或农场使用，无需处方。尽管 1987 年的
《药品法》将大多数抗生素列为“危险药物”，但它只
将其中少量的抗生素列为处方类药物，并未对可以出
售给任何个人的抗生素的数量加以限制。药店工作的
药剂师受该法案中的某些条例的监管，但是其配药和
开药的质量似乎在很大程度上依赖于他们的能力。
结论 在泰国，大多数抗生素很容易从零售药店买到，
无需处方。如要减少对活性药物成分和抗生素的不当
使用，我们需要对某些抗生素进行重新分类和限制销
售，并开发相应系统审核零售部门的抗生素分配和追
踪活性成分的流通。
Résumé
Les circuits de distribution des antibiotiques en Thaïlande: résultats d’entretiens avec des informateurs clés, de revues de la 
réglementation sur les médicaments et de recherches dans des bases de données
Objectif Analyser l’importation, la fabrication, la distribution et la 
réglementation des antibiotiques en Thaïlande.
Méthodes Nous avons rassemblé des informations sur la distribution 
des antibiotiques en Thaïlande à partir d’entretiens approfondis 
avec 43 informateurs clés –provenant d’exploitations agricoles, 
d’établissements de soins, du secteur pharmaceutique et de la 
production d’aliments pour animaux, de pharmacies et d’organismes 
de réglementation privés– et de recherches dans des publications et 
des bases de données.
Résultats En 2016-2017, la distribution d’antibiotiques autorisés 
en Thaïlande a fait intervenir plus de 700 importateurs et environ 
24 000 distributeurs, comme les pharmacies d’officine et les grossistes. 
La Thaïlande importe des antibiotiques et des principes actifs 
pharmaceutiques. Elle n’a pas de système de contrôle de la distribution 
des principes actifs, dont certains sont utilisés directement dans les 
exploitations agricoles, sans traitement préalable. La plupart des 
antibiotiques sont en vente dans les pharmacies, pour usage domestique 
ou agricole, sans ordonnance. Bien que la Loi sur les médicaments de 
1987 ait classé la plupart des antibiotiques comme «médicaments 
dangereux», elle n’en a classé qu’une petite partie en tant que 
médicaments soumis à ordonnance et n’impose aucune restriction sur la 
quantité d’antibiotiques qui peut être vendue à une personne. Certaines 
dispositions de cette Loi s’appliquent aux pharmaciens qui travaillent 
dans des pharmacies, mais il apparaît que la qualité de leur délivrance 
et de leur prescription dépend fortement de leurs compétences.
Conclusion En Thaïlande, la plupart des antibiotiques sont très facilement 
accessibles dans les pharmacies d’officine, sans ordonnance. Si l’on veut 
réduire l’usage inapproprié des principes actifs pharmaceutiques et 
des antibiotiques, il faudra reclasser certains antibiotiques et en limiter 
l’accès, mettre au point des systèmes pour contrôler la délivrance 
d’antibiotiques dans les officines et contrôler les mouvements des 
principes actifs.
Резюме
Каналы распространения антибиотиков в Таиланде: результаты интервью с ключевыми 
информантами, обзоры правового регулирования оборота лекарственных средств и поиск в базах 
данных
Цель Выяснить, каким образом происходит импорт, производство, 
распространение и контроль антибиотиков в Таиланде.
Методы Мы собрали информацию о распространении 
антибиотиков в Таиланде с помощью углубленных интервью с 
43 ключевыми информантами — представителями фермерских 
хозяйств, медицинских учреждений, фармацевтической и 
комбикормовой промышленности, частных аптек и регулирующих 
органов, а также путем поисках в базах данных и научной 
литературе.
Результаты  В 2016–2017 гг.  сеть лицензированного 
распространения антибиотиков в Таиланде включала более 
700 импортеров и около 24 000 дистрибьюторов, таких как 
розничные аптеки и организации оптовой торговли. Таиланд 
импортирует антибиотики и активные фармацевтические 
ингредиенты. При этом в Таиланде отсутствует система 
мониторинга распространения активных ингредиентов, 
некоторые из которых в исходном виде используются 
непосредственно на фермах. Большинство антибиотиков 
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можно купить для домашнего или фермерского использования 
в аптеках без рецепта. Хотя в Законе о продаже рецептурных 
лекарственных средств (Prescription Drug Marketing Act) от 
1987 года большинство антибиотиков классифицированы как 
сильнодействующие лекарственные средства, в то же время в 
этом документе лишь некоторые из них классифицированы как 
лекарственные средства, отпускаемые по рецепту, и отсутствуют 
ограничения по количеству антибиотиков, в котором они могут 
быть отпущены одному лицу. Некоторые положения закона 
распространяются на фармацевтов, работающих в аптеках, но 
качество их назначения и отпуска лекарственных средств, по-
видимому, в значительной степени зависит от их компетенции.
Вывод В Таиланде большинство антибиотиков легко и широко 
доступны в розничных аптеках, где их можно приобрести 
без рецепта. Чтобы сократить ненадлежащее использование 
активных фармацевтических ингредиентов и антибиотиков, 
необходимо повторно их классифицировать, ограничить доступ 
к определенным антибиотикам и разработать системы контроля 
отпуска антибиотиков в розничном секторе и отслеживания 
движения активных ингредиентов.
Resumen 
Canales de distribución de antibióticos en Tailandia: resultados de entrevistas con informantes clave, revisiones de 
regulaciones de medicamentos y búsquedas en bases de datos
Objetivo Analizar cómo se importan, fabrican, distribuyen y regulan 
los antibióticos en Tailandia.
Métodos Recopilamos información sobre la distribución de antibióticos 
en Tailandia, en entrevistas en profundidad, con 43 informadores clave 
de granjas, centros de salud, la industria farmacéutica y alimentación 
animal, farmacias privadas y reguladores, y en búsquedas de bases de 
datos y bibliografía.
Resultados En 2016-2017, en la distribución autorizada de antibióticos 
en Tailandia participan más de 700 importadores y alrededor de 24 000 
distribuidores, p.e. farmacias minoristas y mayoristas. Tailandia importa 
antibióticos y sustancias farmacéuticas activas. No existe un sistema para 
controlar la distribución de los ingredientes activos, algunos de los cuales 
se usan directamente en las granjas, sin ser procesados. La mayoría de 
los antibióticos se pueden comprar en farmacias, para uso doméstico 
o agrícola, sin receta médica. Aunque la Ley de Medicamentos de 1987 
clasificó la mayoría de los antibióticos como “drogas peligrosas”, solo 
clasificó algunos de ellos como medicamentos de venta con receta y 
no restringió las cantidades de antibióticos que podrían venderse a cada 
persona. Los farmacéuticos que trabajan en farmacias están cubiertos 
por algunas de las normas de la Ley, pero la calidad de su dispensación 
y prescripción parece depender en gran medida de sus competencias.
Conclusión En Tailandia, la mayoría de los antibióticos están disponibles 
de forma fácil y general en farmacias minoristas, sin receta médica. 
Para reducir el uso inapropiado de sustancias farmacéuticas activas y 
antibióticos, debemos volver a clasificar y restringir el acceso a ciertos 
antibióticos y desarrollar sistemas para auditar la dispensación de 
antibióticos en el sector minorista y llevar a cabo un seguimiento de 
los movimientos de los ingredientes activos.
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